Neurocrine (NBIX) Director Stephen A. Sherwin Gifts 1,000 Shares

What Happened
Stephen A. Sherwin, a director of Neurocrine Biosciences, reported gifting 1,000 shares on September 2, 2026. The transaction was a gift (code G) and not an open‑market sale or purchase; no price is reported and no value was received for the shares.

Key Details

• Transaction date: 2026-09-02 (reported on Form 4 filed 2026-09-03).
• Transaction type: Gift (code G). Reported price: $0.00 (non‑market transaction). Reported value: $0.
• Shares transferred: 1,000 shares disposed (gifted).
• Shares owned after transaction: Not specified in the provided Form 4.
• Footnote: F1 confirms this was a charitable gift effective Sept 2, 2026; no market price or proceeds.
• Filing timeliness: Form 4 was filed the day after the transaction date; appears to be timely.

Context
Gifts are transfers of ownership (often to charity or family) and do not necessarily indicate the insider’s view on the company’s prospects. They are distinct from purchases (which can signal confidence) and sales (which may be routine or for liquidity). This report documents the transfer for disclosure purposes only.